SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-23-113600
Filing Date
2023-11-02
Accepted
2023-11-02 07:54:45
Documents
8
Effectiveness Date
2023-11-02

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm2329549-1_s3asr.htm S-3ASR 440189
2 EXHIBIT 4.3 tm2329549d2_ex4-3.htm EX-4.3 770470
3 EXHIBIT 4.4 tm2329549d2_ex4-4.htm EX-4.4 598019
4 EXHIBIT 5.1 tm2329549d2_ex5-1.htm EX-5.1 14860
5 EXHIBIT 23.1 tm2329549d2_ex23-1.htm EX-23.1 2524
6 EX-FILING FEES tm2329549d2_ex-filingfees.htm EX-FILING FEES 58535
7 GRAPHIC lg_springworksthera-4c.jpg GRAPHIC 21539
8 GRAPHIC tm2329549d2_ex5-1img001.jpg GRAPHIC 7969
  Complete submission text file 0001104659-23-113600.txt   1926574
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-275262 | Film No.: 231370138
SIC: 2836 Biological Products, (No Diagnostic Substances)